{"schema_version":"secwatch.filing_event.v1","accession":"0001079973-23-001538","form_type":"8-K","ticker":"LCTC","cik":"0001493137","company_name":"Lifeloc Technologies, Inc","filed_at":"2023-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.237043+00:00","generated_at":"2026-06-08T09:14:23.626388+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Lifeloc Q3 net profit $110K, revenue up 33% to $2.696M; SpinDx beta in early 2024","bullets":["Q3 2023 net profit $110K ($0.04 diluted EPS) vs net loss $(87K) ($(0.04) per share) in Q3 2022.","Q3 revenue $2.696M (+33% YoY); gross margin improved to 41.5% from 37.8%.","Nine-month net profit $111K ($0.05 EPS) vs net loss $(433K) ($(0.18) EPS) in prior year.","SpinDx THC saliva test beta expected early 2024, commercialization later 2024; R&D spending up 65%.","Production backlog satisfied as supply chain constraints significantly relieved during Q3."],"urls":{"canonical":"https://secwatch.observer/filing/0001079973-23-001538","json":"https://secwatch.observer/filing/0001079973-23-001538.json","markdown":"https://secwatch.observer/filing/0001079973-23-001538.md","text":"https://secwatch.observer/filing/0001079973-23-001538.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1493137/000107997323001538/0001079973-23-001538-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1493137/000107997323001538/lctc_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T09:14:23.626388+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"976e415ae5600353ad9cd27bbf1cdb7609e7cc22","claim":"Lifeloc Technologies, Inc reported third quarter ended September 30, 2023 results: revenue $2.696 million, net income $110 thousand, EPS $0.04 per diluted share.","evidence_excerpt":"Lifeloc posted quarterly net revenue of $2.696 million in the third quarter of 2023, resulting in a quarterly net profit of $110 thousand, or $0.04 per diluted share.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1493137/000107997323001538/0001079973-23-001538-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended September 30, 2023"},{"label":"Revenue","value":"$2.696 million"},{"label":"Net income","value":"$110 thousand"},{"label":"EPS","value":"$0.04 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}